Gold coating and restenosis after primary stenting of ostial renal artery stenosis. 2003

Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
Department of Angiology, Herz Zentrum Bad Krozingen, Bad Krozingen, Germany. thomas.zeller@herzzentrum.de

Predictors of restenosis after stent angioplasty of ostial renal artery stenosis (RAS) and long-term technical success, particularly the influence of gold coating, are unknown. During a 4-year period (1996-2000), we treated 156 consecutive patients with 219 ostial RAS of > or = 70% diameter stenosis. Gold-coated stents were used in 29% of RAS (n = 64); the vessel diameter ranged from 3 to 9 mm. The restenosis rate was 11.4% at 12 months, 12.2% for gold-coated stents and 11.1% for noncoated stents. Restenosis rates were 16% for < or = 4 mm, 17% for 5 mm, 10% for 6 mm, and 0% for > or = 7 mm (P < or = 0.05). In a backward stepwise logistic regression analysis including gold coating, vessel diameter, gender, diabetes, smoking status, as well as lesion diameter stenosis before and after stenting, vessel diameter was found the only independent predictor of restenosis (odds ratio = 0.57; 95% CI = 0.35-0.93; P = 0.02, for an increase in vessel diameter of 1 mm). Gold coating was not a significant predictor (odds ratio = 1.09; 95% CI = 0.39-3.03; P = 0.87). Seven major (4.5%) complications occurred. There were no procedural fatalities. The restenosis rate after stent angioplasty of ostial RAS is influenced by the vessel diameter but not by gold coating.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006046 Gold A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.
D006083 Graft Occlusion, Vascular Obstruction of flow in biological or prosthetic vascular grafts. Graft Restenosis, Vascular,Vascular Graft Occlusion,Vascular Graft Restenosis,Graft Restenoses, Vascular,Occlusion, Vascular Graft,Restenosis, Vascular Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
March 1998, Annals of vascular surgery,
Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
December 2001, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences,
Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
June 2010, Journal of vascular surgery,
Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
November 2012, Journal of vascular surgery,
Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
January 2000, Texas Heart Institute journal,
Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
January 2021, Annals of vascular surgery,
Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
August 2007, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists,
Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
March 2021, Cardiovascular revascularization medicine : including molecular interventions,
Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
December 2017, Vascular,
Thomas Zeller, and Christian Müller, and Ulrich Frank, and Karlheinz Bürgelin, and Lutz Sinn, and Barbara Horn, and Helmut Roskamm
October 2009, Journal of vascular surgery,
Copied contents to your clipboard!